J&J launches Phase III trial of single-shot Covid-19 vaccine
The placebo-controlled trial, ENSEMBLE, will enroll up to 60,000 healthy volunteers on three continents. The trial will test the vaccine JNJ-78436735, also known as Ad26.COV2.S.
JNJ-78436735